Authors: Roche, L

Citation: L. Roche, Going public, EUR EAT D R, 8(5), 2000, pp. 337-338

Authors: Lefebvre, HP Chetboul, V Klonjkowski, B Pouchelon, JL Roche, L Laroute, V

Citation: Hp. Lefebvre et al., Plasma iohexol and PAH clearances for assessement of glomerular filtrationrate and effective renal plasma flow in dogs: Validation and use in a genetransfer study, REV MED VET, 151(7), 2000, pp. 727-727

Authors: McClarrinon, M Gilkey, L Watral, V Fox, B Bullock, C Fradkin, L Liggitt, D Roche, L Bussey, LB Fox, E Gorman, C

Citation: M. Mcclarrinon et al., In vivo studies of gene expression via transient transgenesis using lipid-DNA delivery, DNA CELL B, 18(7), 1999, pp. 533-547

Authors: Fairman, J Roche, L Pieslak, I Lay, M Corson, S Fox, E Luong, C Koe, G Lemos, B Grove, R Fradkin, L Vernachio, J

Citation: J. Fairman et al., Quantitative RT-PCR to evaluate in vivo expression of multiple transgenes using a common intron, BIOTECHNIQU, 27(3), 1999, pp. 566

Authors: Brady, CP Dowd, AJ Tort, J Roche, L Condon, B O'Neill, SM Brindley, PJ Dalton, JP

Citation: Cp. Brady et al., The cathepsin L-like proteinases of liver fluke and blood fluke parasites of the trematode genera Fasciola and Schistosoma, BIOCH SOC T, 27(4), 1999, pp. 740-745

Authors: Roche, L Tort, J Dalton, JP

Citation: L. Roche et al., The propeptide of Fasciola hepatica cathepsin L is a potent and selective inhibitor of the mature enzyme, MOL BIOCH P, 98(2), 1999, pp. 271-277